title: Estimating the economic burden of inflammatory bowel disease in Canada: physician office visits and mesalamine prescriptions dispensed as surrogate markers.
authors.forename: Victor K
authors.initials: VK
authors.lastname: Wong
authors.forename: Tim K
authors.initials: TK
authors.lastname: Lee
authors.forename: Eric M
authors.initials: EM
authors.lastname: Yoshida
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000465:Algorithms; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000191:economics; D002170:Canada / Q000453:epidemiology; D002648:Child; D005260:Female; D006801:Humans; D015994:Incidence; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy / Q000191:economics* / Q000453:epidemiology*; D008297:Male; D019804:Mesalamine / Q000191:economics* / Q000627:therapeutic use; D008875:Middle Aged; D009819:Office Visits / Q000191:economics*; D015995:Prevalence; D012307:Risk Factors
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D019804:Mesalamine